Recent studies revealed that UDCA imposed anti-tumor effects through multiple pathways via targeting colon cancer cells by downregulating c-Myc protein expression, thereby suppressing proliferation and inducing apoptosis (Peiró-Jordán et al., 2012). The gene discussed is MYC; the disease is malignant colon neoplasm.